RiverVest logo

RiverVest

North America, Missouri, United States, St Louis

Description

RiverVest is a venture capital firm that focuses on identifying and shaping early-stage life science companies to create shareholder value.

Investor Profile

RiverVest has made 89 investments, with 5 in the past 12 months and 20% as lead.

Stage Focus

  • Series B (31%)
  • Series A (26%)
  • Series C (16%)
  • Series D (13%)
  • Series Unknown (9%)
  • Convertible Note (2%)
  • Post Ipo Equity (1%)
  • Series E (1%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Medical Device
  • Biopharma
  • Manufacturing
  • Life Science
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does RiverVest frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 7
3×5 Partners
North America, Oregon, United States, Portland
Co-Investments: 8
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 7
3x5 Special Opportunity Fund
North America, Missouri, United States, St Louis
Co-Investments: 8
Digitalis Ventures
North America, New York, United States, New York
Co-Investments: 7
Novo Ventures
Europe, Hovedstaden, Denmark, Bagsværd
Co-Investments: 7
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 12
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 10
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 7
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 10

Which angels does RiverVest often collaborate with?

Shu Duan
Asia, Hong Kong Island, Hong Kong, Hong Kong
Shared Deals: 1

What are some of recent deals done by RiverVest?

Atalanta Therapeutics

Boston, Massachusetts, United States

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.

BiotechnologyHealth CareLife Science
Series BJan 28, 2025
Amount Raised: $97,000,000
Alleviant Medical

Austin, Texas, United States

Alleviant Medical develops transcatheter technology designed to lift the clinical and economic burden of heart failure.

BiotechnologyClinical TrialsHealth CareMedical Device
Series UnknownJan 14, 2025
Amount Raised: $90,000,000
InterVene

South San Francisco, California, United States

InterVene is a medical device company that treats severe venous disease in the legs.

Health CareMedicalMedical Device
Series AOct 7, 2024
Amount Raised: $13,000,000
Bluejay Therapeutics

San Mateo, California, United States

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

BiotechnologyHealth CarePharmaceutical
Series CMay 9, 2024
Amount Raised: $182,000,000
Sparrow Pharmaceuticals

Portland, Oregon, United States

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series UnknownApr 24, 2024
Amount Raised: $10,200,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series DApr 4, 2024
Amount Raised: $58,000,000
Engrail Therapeutics

San Diego, California, United States

Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.

Health CareLife ScienceMedicalPharmaceutical
Series BMar 19, 2024
Amount Raised: $157,000,000
Avalyn Pharma

Seattle, Washington, United States

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

BiopharmaBiotechnologyMedicalPharmaceutical
Series CSep 27, 2023
Amount Raised: $175,000,000
OncoResponse

Seattle, Washington, United States

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

BiopharmaBiotechnologyHealth CareOncologyTherapeutics
Series DMay 18, 2023
Amount Raised: $14,000,000
Spruce Biosciences

South San Francisco, California, United States

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

BiopharmaBiotechnologyHealth CarePharmaceutical
Post Ipo EquityFeb 9, 2023
Amount Raised: $53,600,000